Print

Tag: counterfeit drugs

Newsletters

Our newsletter features a commentary by Grace-Marie Turner on the major developments and issues of the week as well as summaries of writings by participants in the Health Policy Consensus Group and other articles of interest from the health policy world, plus announcements of coming events. It is emailed in an HTML format from the galen@galen.org email address, via Constant Contact, and you may have to adjust your email settings and junk mailbox to ensure that you don’t miss an issue.
October 31, 2008

Compare and Decide

Political and policy leaders in the U.S. see a new system of “comparative effectiveness reviews” as a solution to many of our problems in the health sector. This is coming, so we need to pay attention. We invited a leading European authority to conduct a seminar yesterday for our colleagues in the policy community to give us an overview. The idea is that a government-commissioned entity would “compare” various medical and pharmaceutical treatments to determine which are “effective” and make “recommendations” for care.
Tags:
comparative effectiveness, Schlander, NICE, health technology assessments, Institut economique Molinari, Grace-Marie Turner, Obama, insurance, importation, counterfeit drugs, Hawaii, Lichtenberg, prescription drugs, Medicaid, FDA, pre-emption, Calfee, concierge care, Arizona, Proposition 101, Freedom of Choice in Health Care, McCain, Entin, IRET
Categories:
Comparative Effectiveness


October 9, 2008

Health Care Week

Health care hit the first tier in the presidential election campaigns this week, with charges and counter-charges flying on the campaign trail and in the media. The stack of new papers and articles on my desk out just this week on the health reform debate is an inch thick. Here are some highlights of reports that offer actual facts and new insights.
Tags:
Galen Institute, McCain, Obama, Wall Street Journal, New York Times, National Review, Washington Post, Business Roundtable, business, Feldman, HSI Network, Sheils, Lewin Group, prescription drugs, Scott Gottlieb, AEI, counterfeit drugs, India, biologics, Merrill Matthews, IPI, CAHI, voters, health insurance, Canada, wait list, Fraser Institute, Massachusetts, ER
Categories:
2008 Election